Eligibility for subcutaneous implantable cardioverter‐defibrillator in adults with congenital heart disease

AIMS: Patients with adult congenital heart disease (ACHD) carry an increased risk for sudden cardiac death. Implantable cardioverter‐defibrillator (ICD) therapy may be challenging in these patients due to anatomical barriers, repeated cardiac surgery, or complicated transvenous access. Thus, the sub...

Descripción completa

Detalles Bibliográficos
Autores principales: Zormpas, Christos, Silber‐Peest, Ann Sophie, Eiringhaus, Jörg, Hillmann, Henrike A.K., Hohmann, Stephan, Müller‐Leisse, Johanna, Westhoff‐Bleck, Mechthild, Veltmann, Christian, Duncker, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006645/
https://www.ncbi.nlm.nih.gov/pubmed/33538124
http://dx.doi.org/10.1002/ehf2.13243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006645/
https://www.ncbi.nlm.nih.gov/pubmed/33538124
http://dx.doi.org/10.1002/ehf2.13243

Ejemplares similares